Table 1.
Characteristics of Conventional Genotypic, Phenotypic, and Ultrasensitive Drug Resistance Assays
Assay | Advantages | Disadvantages | Currently in Clinical Use |
---|---|---|---|
Conventional genotypic (Sanger DNA sequencing) |
|
|
Yes |
Phenotypic |
|
|
Yes |
Ultrasensitive techniques | |||
Allele-specific polymerase chain reaction |
|
|
No |
Deep sequencingb |
|
|
Yesc |
Oligonucleotide ligation assay |
|
|
No |
Adapted from [104].
a Test sensitivity and limits of detection vary by testing site and patient-specific variables (eg, viral load, sample volume).
b Refers to the Roche/454, Illumina, and other next-generation sequencing platforms.
c The Roche/454 deep-sequencing system is currently used as part of a coreceptor tropism test developed by Quest Diagnostics (Madison, New Jersey).